Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression-Reference-Cited by-同舟云学术

Hyperhomocysteinemia Promotes Insulin Resistance and Adipose Tissue Inflammation in PCOS Mice Through Modulating M2 Macrophage Polarization via Estrogen Suppression

Published:2017-03-15 Issue:5 Volume:158 Page:1181-1193
ISSN:0013-7227
Container-title:Endocrinology
language:en
Short-container-title:

Author:

Qi Xinyu¹²³,Zhang Bochun¹²³,Zhao Yue¹²³,Li Rong¹²³,Chang Hsun-Ming¹²,Pang Yanli¹²³,Qiao Jie¹²³

Affiliation:

1. Reproductive Medical Center, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China

2. Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Beijing 100191, China

3. Key Laboratory of Assisted Reproduction, Ministry of Education, Beijing 100191, China

Publisher

The Endocrine Society

Subject

Endocrinology

Link

http://academic.oup.com/endo/article-pdf/158/5/1181/14069261/en.2017-00039.pdf

Reference44 articles.

1. Polycystic ovary syndrome: update on diagnosis and treatment;Setji;Am J Med,2014

2. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment;Deugarte;Fertil Steril,2005

3. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome;Ciaraldi;J Clin Endocrinol Metab,1992

4. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity;Heilbronn;Curr Pharm Des,2008

5. Macrophages, inflammation, and insulin resistance;Olefsky;Annu Rev Physiol,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From proteome to pathogenesis: investigating polycystic ovary syndrome with Mendelian randomization analysis;Frontiers in Endocrinology;2024-09-09

2. Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice;Drug Design, Development and Therapy;2024-09

3. Use of placental-derived mesenchymal stem cells to restore ovarian function and metabolic profile in a rat model of the polycystic ovarian syndrome;BMC Endocrine Disorders;2024-08-19

4. Revitalizing polycystic ovary syndrome: The therapeutic impact of low-dose ^△ 9 tetrahydrocannabinol through reduction of oxidative stress and modulation of macrophage polarization;IRAN J BASIC MED SCI;2024

5. Effects of MTHFR C677T polymorphism on homocysteine and vitamin D in women with polycystic ovary syndrome;Gene;2024-08